Commercially available assays for multiplex detection of alpha human papillomaviruses.

作者: Mario Poljak , Boštjan J Kocjan

DOI: 10.1586/ERI.10.104

关键词: MultiplexRoutine screeningClinical valueAlpha (ethology)GenotypingCervical cancerGenotypeHpv detectionMolecular biologyBiologyVirology

摘要: … Several in-house HPV DNA detection methods have been … commercial assays for multiplex detection of alpha-HPV. … commercial assays for the multiplex detection of alpha-HPVs have …

参考文章(157)
PETER J.F. SNIJDERS, DANIËLLE A.M. HEIDEMAN, CHRIS J.L.M. MEIJER, Methods for HPV detection in exfoliated cell and tissue specimens Apmis. ,vol. 118, pp. 520- 528 ,(2010) , 10.1111/J.1600-0463.2010.02621.X
Ni Li, Silvia Franceschi, Rebecca Howell-Jones, Peter J.F. Snijders, Gary M. Clifford, Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. International Journal of Cancer. ,vol. 128, pp. 927- 935 ,(2011) , 10.1002/IJC.25396
A Kathrine Lie, Gunnar Kristensen, Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma Expert Review of Molecular Diagnostics. ,vol. 8, pp. 405- 415 ,(2008) , 10.1586/14737159.8.4.405
Philip E Castle, Janel Dockter, Cristina Giachetti, Francisco AR Garcia, Mary Kay McCormick, Amy L Mitchell, E Blair Holladay, Daniel P Kolk, None, A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer Clinical Cancer Research. ,vol. 13, pp. 2599- 2605 ,(2007) , 10.1158/1078-0432.CCR-06-2881
Paul S. Eder, Jianrong Lou, John Huff, Jerzy Macioszek, The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform. Journal of Clinical Virology. ,vol. 45, ,(2009) , 10.1016/S1386-6532(09)70013-7
Anna R. Giuliano, Guillermo Tortolero-Luna, Elena Ferrer, Ann N. Burchell, Silvia de Sanjose, Susanne Kruger Kjaer, Nubia Muñoz, Mark Schiffman, F. Xavier Bosch, Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions Vaccine. ,vol. 26, ,(2008) , 10.1016/J.VACCINE.2008.06.021
M.A. De Francesco, F. Gargiulo, C. Schreiber, G. Ciravolo, F. Salinaro, N. Manca, Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear Journal of Virological Methods. ,vol. 147, pp. 10- 17 ,(2008) , 10.1016/J.JVIROMET.2007.07.023
M. Mirasoli, M. Guardigli, P. Simoni, S. Venturoli, S. Ambretti, M. Musiani, A. Roda, Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia Analytical and Bioanalytical Chemistry. ,vol. 394, pp. 981- 987 ,(2009) , 10.1007/S00216-009-2707-Y
Mark H Einstein, Mark G Martens, Francisco AR Garcia, Daron G Ferris, Amy L Mitchell, Stephen P Day, Marilyn C Olson, None, Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology Gynecologic Oncology. ,vol. 118, pp. 116- 122 ,(2010) , 10.1016/J.YGYNO.2010.04.013
Kate S. Cuschieri, M.J. Whitley, Heather A. Cubie, Human papillomavirus type specific DNA and RNA persistence: Implications for cervical disease progression and monitoring Journal of Medical Virology. ,vol. 73, pp. 65- 70 ,(2004) , 10.1002/JMV.20062